Top 5 Key Players of Apomorphine Hydrochloride Market, 2023
Dopamine agonists are a class of medications that includes apomorphine. Parkinson's disease, a degenerative nervous system condition that impairs movement, is treated with it. Dopamine agonists are drugs that replicate the effects of dopamine, such as apomorphine. The brain produces dopamine, a neurotransmitter that serves as a messenger for information transfer between nerve cells (neurons). By attaching to dopamine receptors in the brain and mimicking natural dopamine, apomorphine helps cure Parkinson's disease. Parkinson's disease symptoms are thought to be brought on by low levels of dopamine.
Dopamine agonist Apokyn (apomorphine hydrochloride injection) is used to treat the wear-off of muscle stiffness and loss of motor control in persons with severe Parkinson's disease. It works by aiding in the restoration of the balance of dopamine in the brain. Apomorphine is sold as an injectable solution for use in medical procedures. When necessary, apomorphine is often administered. Glass packaging makes apomorphine solution convenient to use with an injector pen. Additional needles can be purchased separately, and certain needles are given with pens.
"According to Business Research Insights, the global"" market size for ""Apomorphine Hydrochloride"" i""s valued at USD ""289.5"" million in 20""22 ""and is projected to reach a valuation of USD"" 364.1"" million by 202""8"" with a CAGR of ""3.9""%. The market has leading players; ""US WorldMeds LLC"", ""Supernus Pharmaceuticals"", ""Britannia Pharmaceuticals STADA"", ""Ever Pharma"", ""Evolan Pharma AB (PharmSwed)"",""Tianjin Tianwei Pharmaceutical"", ""Sunovion""."
"Business Research Insights States Top 5 ""Apomorphine Hydrochloride"" Companies- "
1. US WorldMeds, LLC (U.S.)
A privately held specialized pharmaceutical firm called US WorldMeds creates, licences, and markets innovative healthcare solutions with the goal of enhancing the lives of people with difficult medical conditions and unmet needs. In the therapeutic fields of haemophilia, malignant hyperthermia, and opioid use disorder medicine, US WorldMeds has developed a portfolio of branded products. In both the medicines that are currently being developed and the products that we market, US WorldMeds is dedicated to bettering the lives of our patients. This dedication is evident in our pipeline, where we are tirelessly working to provide patients across numerous therapeutic areas with novel medicines and new indications.
2. Supernus Pharmaceuticals (U.S.)
A biopharmaceutical firm called Supernus Pharmaceuticals is dedicated to creating and marketing drugs to treat conditions of the central nervous system (CNS). We have developed a deep level of product development knowledge over the past 30 years. We began as a stand-alone development company, later became a U.S. subsidiary of Shire plc, and finally changed our name to Supernus Pharmaceuticals, Inc. in late 2005. Its goal is to make patients' lives better who are dealing with central nervous system disorders (CNS).
3. Britannia Pharmaceuticals STADA "(U.""K"".)"
Britannia was established in 1982 as a tiny, family-run company that specialised in niche remedies. Since then, it has grown successfully to become a leading global centre of excellence for specialty pharmaceuticals. Our main area of interest has been the creation of cutting-edge, patient-focused technology for more than 30 years that successfully administers treatments to Parkinson's disease patients. We collaborate with specialized focus groups, provide funding for clinical trials, and support care initiatives that enhance treatment plans and quality of life.
"4. EVER Pharma"" (""Austria"")"
The research, development, manufacturing, and commercialization of medicines in the fields of neurology and speciality injectables, including oncology, intensive care, and hormone treatments, are the main goals of EVER Pharma, a seamless integration specialty pharmaceuticals company. They operate a vibrant business from our headquarters in Austria, offering cutting-edge goods and formulations with added value to improve the quality of life for patients while assisting healthcare professionals in their work by boosting convenience and safety.
Their goods are created and produced at our Austrian and German facilities that have received EU GMP certification. These have a high level of specialization in the manufacture of complicated injectables, such as high potency and regulated drugs, crystal suspensions, oily solutions in vials, pre-filled syringes, cartridges, implants, and ampoules. Through our own foreign affiliates and strategic partners, they advertise our products in more than 70 different countries across the world.
5. Tianjin Tianwei Pharmaceutical"(""China"")"
The state-owned Tianjin Pharmaceutical Group is a sizable, all-encompassing pharmaceutical company with four key business segments: chemical and biopharmaceutical, green Chinese medicine, upscale medical technology, and contemporary commercial logistics. It has integrated research, production, and commercial sales and has more than 100 holdings or Participating companies. Three new listed companies, Sino-Singapore, Tianyao, and Lisheng Pharmaceutical, are also part of this organization. It has also collaborated with various multinational pharmaceutical groups to form more than 10 joint ventures. The Group has consistently been chosen as one of the top 500 Chinese companies and its key economic metrics are among the best in China's pharmaceutical sector.
"Progressive Mechanism of ""Apomorphine Hydrochloride"" to Pose an Opportunity for Market Growth"
The market for apomorphine hydrochloride has undergone remarkable development in recent years and is predicted to expand significantly throughout the forecast period. Parkinson's disease, which causes issues with movement, muscular control, and balance in patients taking other drugs for their illness, is treated with apomorphine hydrochloride. It belongs to a group of drugs known as dopamine agonists and functions by taking the role of dopamine, a naturally occurring chemical released in the brain that is essential for controlling movement.
Our Clients
